Anti-apoptosis Proteins Mcl-1 and Bcl-xL Have Different P53-Binding Profiles.

Hongwei Yao,Shuofu Mi,Weibin Gong,Jian Lin,Nuo Xu,Sarah Perrett,Bin Xia,Jinfeng Wang,Yingang Feng

DOI: https://doi.org/10.1021/bi400690m

IF: 3.321

2013-01-01

Biochemistry

Abstract:One of the transcription-independent mechanisms of the tumor suppressor p53 discovered in recent years involves physical interaction between p53 and proteins of the Bcl-2 family. In this paper, significant differences between the interaction of p53 with Mcl-1 and Bcl-xL were demonstrated by NMR spectroscopy and isothermal titration calorimetry. Bcl-xL was found to bind strongly to the p53 DNA-binding domain (DBD) with a dissociation constant (K-d) of similar to 600 nM, whereas Mcl-1 binds to the p53 DBD weakly with a dissociation constant in the mM range. In contrast, the p53 transactivation domain (TAD) binds weakly to Bcl-xL with a K-d similar to 300-500 mu M and strongly to Mcl-1 with a K-d similar to 10-20 mu M. NMR titrations indicate that although the p53 TAD binds to the BH3-binding grooves of both Bcl-xL and Mcl-1, Bcl-xL prefers to bind to the first subdomain (TAD1) in the p53 TAD, and Mcl-1 prefers to bind to the second subdomain (TAD2). Therefore, Mcl-1 and Bcl-xL have different p53-binding profiles. This indicates that the detailed interaction mechanisms are different, although both Mcl-1 and Bcl-xL can mediate transcription-independent cytosolic roles of p53. The revealed differences in binding sites and binding affinities should be considered when BH3 mimetics are used in cancer therapy development.